Skip to main content

Yoghurts Containing Probiotics Reduce Disruption of the Small Intestinal Barrier in Methotrexate-Treated Rats

Abstract

Small intestinal permeability was employed to assess the efficacy of commercially available yoghurts containing probiotics in a rat model of methotrexate (MTX)-induced mucositis. Male Sprague-Dawley rats were allocated to four groups (n = 8): MTX + water, MTX + cow’s milk yoghurt (CY; fermented with Lactobacillus johnsonii), MTX + sheep’s milk yoghurt (SY; containing Lactobacillus bulgaricus and Streptococcus thermophilus), and saline. Treatment gavage occurred twice daily for 7 days pre-MTX and 5 days post-MTX. Intestinal permeability was assessed on days −7, −1, 2, and 5 of the trial. Intestinal sections were collected at sacrifice for histological and biochemical analyses. Histology revealed that rats receiving CY and SY did not have a significantly damaged duodenum compared to controls. However, an improved small intestinal barrier function was evident, determined by a decreased lactulose/mannitol ratio. Probiotics containing SY and CY may be useful in preventing disruption to intestinal barrier function in MTX-induced mucositis.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Keefe DMK, Brealey J, Goland GJ, Cummins AG (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47:632–637

    Article  PubMed  CAS  Google Scholar 

  2. Taminiau JAJM, Gall DG, Hamilton JR (1980) Response of the rat small-intestine epithelium to methotrexate. Gut 21:486–492

    Article  PubMed  CAS  Google Scholar 

  3. Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Molin G, Jeppsson B (1996) The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111:334–344

    Article  PubMed  CAS  Google Scholar 

  4. Keefe DMK, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE (1997) Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci 92:385–389

    PubMed  CAS  Google Scholar 

  5. Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73:1142S–1146S

    PubMed  CAS  Google Scholar 

  6. Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531–536

    Article  PubMed  CAS  Google Scholar 

  7. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T (1991) A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88:90–97

    PubMed  CAS  Google Scholar 

  8. Gionchetti P, Amadini C, Rizzello F, Venturi A, Palmonari V, Morselli C, Romagnoli R, Campieri M (2002) Probiotics—role in inflammatory bowel disease. Dig Liver Dis 34(Suppl 2):S58–S62

    Article  PubMed  Google Scholar 

  9. Czerucka D, Rampal P (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4:733–739

    Article  PubMed  Google Scholar 

  10. Tomas FM, Knowles SE, Owens PC, Read LC, Chandler CS, Gargosky SE, Ballard FJ (1991) Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. J Endocrinol 128:97–105

    Article  PubMed  CAS  Google Scholar 

  11. Howarth GS, Francis GL, Cool JC, Xu X, Byard RW, Read LC (1996) Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 126:2519–2530

    PubMed  CAS  Google Scholar 

  12. Miki K, Butler R, Moore D, Davidson G (1996) Rapid and simultaneous quantification of rhamnose, mannitol and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice. Clin Chem 42:1–5

    Google Scholar 

  13. Shirazi-Beechey SP, Davies AG, Tebbutt K, Dyer J, Ellis A, Taylor CJ, Fairclough P, Beechey RB (1990) Preparation and properties of brush-border membrane vesicles from human small intestine. Gastroenterology 98:676–685

    PubMed  CAS  Google Scholar 

  14. Dahlqvist A (1968) Assay of intestinal disaccharidases. Anal Biochem 22:99–107

    Article  PubMed  CAS  Google Scholar 

  15. Pelton NS, Tivey DR, Howarth GS, Davidson GP, Butler RN (2004) A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastroenterol 39:1015–1016

    Article  PubMed  CAS  Google Scholar 

  16. Lee MF, Russell RM, Montgomery RK, Krasinski SD (1997) Total intestinal lactase and sucrase activities are reduced in aged rats. J Nutr 127:1382–1387

    PubMed  CAS  Google Scholar 

  17. Jang I, Jung K, Cho J (2000) Influence of age on duodenal brush border membrane and specific activities of brush border membrane enzymes in Wistar rats. Exp Anim 49:281–287

    Article  PubMed  CAS  Google Scholar 

  18. Tooley KL, Howarth GS, Lymn K, Lawrence A, Butler RN (2006) Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol Ther 5:593–600

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. N. Butler.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Southcott, E., Tooley, K.L., Howarth, G.S. et al. Yoghurts Containing Probiotics Reduce Disruption of the Small Intestinal Barrier in Methotrexate-Treated Rats. Dig Dis Sci 53, 1837–1841 (2008). https://doi.org/10.1007/s10620-008-0275-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0275-1

Keywords

  • Methotrexate
  • Mucositis
  • Small intestine
  • Permeability
  • Barrier function
  • Probiotics